Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Compounding is important for investors as it maximizes potential returns over time. Discover its significance in your investment strategy.
27,336 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
After a stunning quarterly update, Micron stock tumbled on fears about memory cycles. This guide breaks down why the ...
Bitcoin’s wild moves test every investor, even high-profile ones. This piece dives into Dave Portnoy’s experience, th...
Geopolitics are shaking energy markets, but savvy investors can find steadiness. This piece explains how Iran roiling...
Markets can climb for years, but today’s warning signs hint at a tougher road ahead. This guide breaks down the histo...
Looking ahead at geron (gern) 2026 earnings, this guide breaks down the catalysts, cash runway, and risks shaping the...
Paradigm just closed a $1.2B fund, signaling a bold move at the intersection of crypto and AI. This Morning Minute ex...
Nvidia's next earnings report may hinge on a single, less-obvious metric. This article explains what that figure is, ...
Per Stirling Capital Management increased its stake in the First Trust Smith Opportunistic Fixed Income ETF (FIXD) by...
A high-level insider move follows a strong stock run. This article breaks down what the CFO’s sale signals, how to re...
As markets wobble in early 2026, preferred shares matter for investors seeking steady income and lower drama than gro...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...